OxySure Systems, a medical technology company that has pioneered an FDA-approved solution to produce medically pure oxygen from dry, inert powders for emergency and short duration use, reported the launch of OxySure Commercial Finance(NYSE:SM), a service that enables easy and convenient lease of OxySure's suite of medical devices and products, including the OxySure Model 615, Automated External Defibrillators (AEDs), and other medical equipment, supplies and accessories.
Powered by LeaseQ, OxySure's new service allows customers to do comparison shopping for lease quotes from dozens of third party lenders with one simple online form that takes only two minutes to complete. The system can pre-qualify customers instantly and display the top results, allowing customers to select from multiple, pre-qualified offers. The system also provides customers the flexibility to select lenders of choice and payment plan characteristics such as monthly payment, finance term and terminal value.
Julian T. Ross, CEO of OxySure, stated, "We are excited about the OxySure Commercial Finance(SM) program because the program makes it easy to differentiate OxySure sales with financing options wherever OxySure products are sold. By offering our customers the opportunity of an attractive monthly cost via third party financing, OxySure products and solutions become significantly more affordable. The program can also facilitate or fast track the purchasing process and can typically provide tax advantages to corporate buyers."
More information can be found by visiting the following link: www.oxysure.com/aed/index.php/lease-financing
QualityStocks provides investor relations services to publicly traded companies in exchange for compensation. This article may be part of our efforts to widen a client's exposure. To read our full disclaimer, visit http://disclaimer.qualitystocks.net